Wireless neurochemical monitoring in humans

Stereotactic and Functional Neurosurgery

Volumn 91, Issue 3, 2013, Pages 141-147

  Kasasbeh, Aimen ^a   Lee, Kendall ^a   Bieber, Allan ^a   Bennet, Kevin ^a   Chang, Su Youne ^a  

^a MAYO CLINIC   (United States)

Author keywords

Electrochemisty; Humans; WINCS

Indexed keywords

ADENOSINE; NEUROTRANSMITTER; ADRENALIN; DOPAMINE; GLUTAMIC ACID; HISTAMINE; NORADRENALIN; SEROTONIN;

AMPEROMETRY; CYCLIC POTENTIOMETRY; DIFFERENTIAL PULSE VOLTAMMETRY; ELECTROCHEMICAL ANALYSIS; ELECTROCHEMISTRY; HUMAN; MEDICAL TECHNOLOGY; NEUROMONITORING; OPERATING ROOM; RECORDING; REVIEW; TELEMETRY; THALAMUS; COMPUTER PROGRAM; MEMBRANE STEADY POTENTIAL; MICROPROCESSOR; MOLECULAR SENSOR; MONITOR; NEUROCHEMISTRY; NEUROLOGICAL EQUIPMENT; REAL TIME FAST SCAN CYCLIC VOLTAMMETRY; WIRELESS INSTANTANEOUS NEUROTRANSMITTER CONCENTRATION SENSING SYSTEM; WIRELESS NEUROCHEMICAL MONITORING;

BIOSENSING TECHNIQUES; ELECTROCHEMICAL TECHNIQUES; HUMANS; TELEMETRY; WIRELESS TECHNOLOGY;

EID: 84874243365     PISSN: 10116125     EISSN: 14230372     Source Type: Journal    
DOI: 10.1159/000345111     Document Type: Review

References (58)

1. Hou B, Jiang T, Liu R: Deep-brain stimulation for Parkinson's disease. N Engl J Med 2010; 363: 987-988.
2. Follett KA, Torres-Russotto D: Deep brain stimulation of globus pallidus interna, subthalamic nucleus, and pedunculopontine nucleus for Parkinson's disease: which target? Parkinsonism Relat Disord 2012; 18 (suppl 1):S165-S167.
3. Benabid AL, Chabardes S, Mitrofanis J, Pollak P: Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 2009; 8: 67-81.
4. Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Benabid AL, Cornu P, Lagrange C, Tezenas du MS, Dormont D, Grand S, Blond S, Detante O, Pillon B, Ardouin C, Agid Y, Destee A, Pollak P: Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 2005; 352: 459-467.
5. Speelman JD, Contarino MF, Schuurman PR, Tijssen MA, de Bie RM: Deep brain stimulation for dystonia: patient selection and outcomes. Eur J Neurol 2010; 17(suppl 1):102-106.
6. Ostrem JL, Racine CA, Glass GA, Grace JK, Volz MM, Heath SL, Starr PA: Subthalamic nucleus deep brain stimulation in primary cervical dystonia. Neurology 2011; 76: 870-878.
7. Lind G, Schechtmann G, Lind C, Winter J, Meyerson BA, Linderoth B: Subthalamic stimulation for essential tremor. Short-and long-term results and critical target area. Stereotact Funct Neurosurg 2008; 86: 253-258.
8. Papavassiliou E, Rau G, Heath S, Abosch A, Barbaro NM, Larson PS, Lamborn K, Starr PA: Thalamic deep brain stimulation for essential tremor: relation of lead location to outcome. Neurosurgery 2008; 62(suppl 2): 884-894.
9. Hariz GM, Blomstedt P, Koskinen LO: Longterm effect of deep brain stimulation for essential tremor on activities of daily living and health-related quality of life. Acta Neurol Scand 2008; 118: 387-394.
10. Edwards TC, Zrinzo L, Limousin P, Foltynie T: Deep brain stimulation in the treatment of chorea. Mov Disord 2012; 27: 357-363.
11. Apetauerova D, Schirmer CM, Shils JL, Zani J, Arle JE: Successful bilateral deep brain stimulation of the globus pallidus internus for persistent status dystonicus and generalized chorea. J Neurosurg 2010; 113: 634-638.
12. Pereira EA, Green AL, Stacey RJ, Aziz TZ: Refractory epilepsy and deep brain stimulation. J Clin Neurosci 2012; 19: 27-33.
13. Boon P, Vonck K, De Herdt V, Van Dycke A, Goethals M, Goossens L, Van Zandijcke M, De Smedt T, Dewaele I, Achten R, Wadman W, Dewaele F, Caemaert J, Van Roost D: Deep brain stimulation in patients with refractory temporal lobe epilepsy. Epilepsia 2007; 48: 1551-1560.
14. Lee KJ, Jang KS, Shon YM: Chronic deep brain stimulation of subthalamic and anterior thalamic nuclei for controlling refractory partial epilepsy. Acta Neurochir Suppl 2006; 99: 87-91.
15. Thomas L, Bledsoe JM, Stead M, Sandroni P, Gorman D, Lee KH: Motor cortex and deep brain stimulation for the treatment of intractable neuropathic face pain. Curr Neurol Neurosci Rep 2009; 9: 120-126.
16. Sillay KA, Sani S, Starr PA: Deep brain stimulation for medically intractable cluster headache. Neurobiol Dis 2010; 38: 361-368.
17. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH: Deep brain stimulation for treatment-resistant depression. Neuron 2005; 45: 651-660.
18. Puigdemont D, Perez-Egea R, Portella MJ, Molet J, de Diego-Adelino J, Gironell A, Radua J, Gomez-Anson B, Rodriguez R, Serra M, de QC, Artigas F, Alvarez E, Perez V: Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression. Int J Neuropsychopharmacol 2011: 1-13.
19. Denys D, Mantione M, Figee M, van den Munckhof P, Koerselman F, Westenberg H, Bosch A, Schuurman R: Deep brain stimulation of the nucleus accumbens for treatmentrefractory obsessive-compulsive disorder. Arch Gen Psychiatry 2010; 67: 1061-1068.
20. Komotar RJ, Hanft SJ, Connolly ES Jr: Deep brain stimulation for obsessive compulsive disorder. Neurosurgery 2009; 64:N13.
21. Burdick AP, Foote KD: Advancing deep brain stimulation for obsessive-compulsive disorder. Expert Rev Neurother 2011; 11: 341-344.
22. Cavanna AE, Eddy CM, Mitchell R, Pall H, Mitchell I, Zrinzo L, Foltynie T, Jahanshahi M, Limousin P, Hariz MI, Rickards H: An approach to deep brain stimulation for severe treatment-refractory Tourette syndrome: the UK perspective. Br J Neurosurg 2011; 25: 38-44.
23. Hariz MI, Robertson MM: Gilles de la Tourette syndrome and deep brain stimulation. Eur J Neurosci 2010; 32: 1128-1134.
24. Porta M, Brambilla A, Cavanna AE, Servello D, Sassi M, Rickards H, Robertson MM: Thalamic deep brain stimulation for treatmentrefractory Tourette syndrome: two-year outcome. Neurology 2009; 73: 1375-1380.
25. Savica R, Stead M, Mack KJ, Lee KH, Klassen BT: Deep brain stimulation in Tourette syndrome: a description of 3 patients with excellent outcome. Mayo Clin Proc 2012; 87: 59-62.
26. Kishida KT, Sandberg SG, Lohrenz T, Comair YG, Saez I, Phillips PE, Montague PR: Sub-second dopamine detection in human striatum. PLoS One 2011; 6:e23291.
27. Lee KH, Blaha CD, Harris BT, Cooper S, Hitti FL, Leiter JC, Roberts DW, Kim U: Dopamine efflux in the rat striatum evoked by electrical stimulation of the subthalamic nucleus: potential mechanism of action in Parkinson's disease. Eur J Neurosci 2006; 23: 1005-1014.
28. Shon YM, Lee KH, Goerss SJ, Kim IY, Kimble C, Van Gompel JJ, Bennet K, Blaha CD, Chang SY: High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery. Neurosci Lett 2010; 475: 136-140.
29. Lee KH, Kristic K, van Hoff R, Hitti FL, Blaha C, Harris B, Roberts DW, Leiter JC: High-frequency stimulation of the subthalamic nucleus increases glutamate in the subthalamic nucleus of rats as demonstrated by in vivo enzyme-linked glutamate sensor. Brain Res 2007; 1162: 121-129.
30. Chang SY, Shon YM, Agnesi F, Lee KH: Microthalamotomy effect during deep brain stimulation: potential involvement of adenosine and glutamate efflux. Conf Proc IEEE Eng Med Biol Soc 2009; 2009: 3294-3297.
31. Lee KH, Chang SY, Roberts DW, Kim U: Neurotransmitter release from high-frequency stimulation of the subthalamic nucleus. J Neurosurg 2004; 101: 511-517.
32. Bekar L, Libionka W, Tian GF, Xu Q, Torres A, Wang X, Lovatt D, Williams E, Takano T, Schnermann J, Bakos R, Nedergaard M: Adenosine is crucial for deep brain stimulationmediated attenuation of tremor. Nat Med 2008; 14: 75-80.
33. Shon YM, Chang SY, Tye SJ, Kimble CJ, Bennet KE, Blaha CD, Lee KH: Comonitoring of adenosine and dopamine using the Wireless Instantaneous Neurotransmitter Concentration System: proof of principle. J Neurosurg 2010; 112: 539-548.
34. Griessenauer CJ, Chang SY, Tye SJ, Kimble CJ, Bennet KE, Garris PA, Lee KH: Wireless Instantaneous Neurotransmitter Concentration System: electrochemical monitoring of serotonin using fast-scan cyclic voltammetry-a proof-of-principle study. J Neurosurg 2010; 113: 656-665.
35. Abosch A, Kapur S, Lang AE, Hussey D, Sime E, Miyasaki J, Houle S, Lozano AM: Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release. Neurosurgery 2003; 53: 1095-1102.
36. Thobois S, Fraix V, Savasta M, Costes N, Pollak P, Mertens P, Koudsie A, Le Bars D, Benabid AL, Broussolle E: Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease-A [(11)C]-raclopride PET study. J Neurol 2003; 250: 1219-1223.
37. Hilker R, Voges J, Ghaemi M, Lehrke R, Rudolf J, Koulousakis A, Herholz K, Wienhard K, Sturm V, Heiss WD: Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans. Mov Disord 2003; 18: 41-48.
38. Lee KH, Blaha CD, Garris PA, Mohseni P, Horne AE, Bennet KE, Agnesi F, Bledsoe JM, Lester DB, Kimble C, Min HK, Kim YB, Cho ZH: Evolution of deep brain stimulation: human electrometer and smart devices supporting the next generation of therapy. Neuromodulation 2009; 12: 85-103.
39. Peters JL, Miner LH, Michael AC, Sesack SR: Ultrastructure at carbon fiber microelectrode implantation sites after acute voltammetric measurements in the striatum of anesthetized rats. J Neurosci Methods 2004; 137: 9-23.
40. Blaha CD, Phillips AG: A critical assessment of electrochemical procedures applied to the measurement of dopamine and its metabolites during drug-induced and species-typical behaviours. Behav Pharmacol 1996; 7: 675-708.
41. Borland LM, Michael AC: Voltammetric study of the control of striatal dopamine release by glutamate. J Neurochem 2004; 91: 220-229.
42. Robinson DL, Hermans A, Seipel AT, Wightman RM: Monitoring rapid chemical communication in the brain. Chem Rev 2008; 108: 2554-2584.
43. Blaha CD, Coury A, Fibiger HC, Phillips AG: Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis. Neuroscience 1990; 34: 699-705.
44. Agnesi F, Tye SJ, Bledsoe JM, Griessenauer CJ, Kimble CJ, Sieck GC, Bennet KE, Garris PA, Blaha CD, Lee KH: Wireless Instantaneous Neurotransmitter Concentration System-based amperometric detection of dopamine, adenosine, and glutamate for intraoperative neurochemical monitoring. J Neurosurg 2009; 111: 701-711.
45. Swamy BE, Venton BJ: Carbon nanotubemodified microelectrodes for simultaneous detection of dopamine and serotonin in vivo. Analyst 2007; 132: 876-884.
46. Van Gompel JJ, Chang SY, Goerss SJ, Kim IY, Kimble C, Bennet KE, Lee KH: Development of intraoperative electrochemical detection: wireless instantaneous neurochemical concentration sensor for deep brain stimulation feedback. Neurosurg Focus 2010; 29:E6.
47. Bledsoe JM, Kimble CJ, Covey DP, Blaha CD, Agnesi F, Mohseni P, Whitlock S, Johnson DM, Horne A, Bennet KE, Lee KH, Garris PA: Development of the Wireless Instantaneous Neurotransmitter Concentration System for intraoperative neurochemical monitoring using fast-scan cyclic voltammetry. J Neurosurg 2009; 111: 712-723.
48. Kimble CJ, Johnson DM, Winter BA, Whitlock SV, Kressin KR, Horne AE, Robinson JC, Bledsoe JM, Tye SJ, Chang SY, Agnesi F, Griessenauer CJ, Covey D, Shon YM, Bennet KE, Garris PA, Lee KH: Wireless Instantaneous Neurotransmitter Concentration Sensing System (WINCS) for intraoperative neurochemical monitoring. Conf Proc IEEE Eng Med Biol Soc 2009; 2009: 4856-4859.
49. Koehne JE, Marsh M, Boakye A, Douglas B, Kim IY, Chang SY, Jang DP, Bennet KE, Kimble C, Andrews R, Meyyappan M, Lee KH: Carbon nanofiber electrode array for electrochemical detection of dopamine using fast scan cyclic voltammetry. Analyst 2011; 136: 1802-1805.
50. Garris PA, Ensman R, Poehlman J, Alexander A, Langley PE, Sandberg SG, Greco PG, Wightman RM, Rebec GV: Wireless transmission of fast-scan cyclic voltammetry at a carbon-fiber microelectrode: proof of principle. J Neurosci Methods 2004; 140: 103-115.
51. Chang SY, Kim I, Marsh MP, Jang DP, Hwang SC, Van Gompel JJ, Goerss SJ, Kimble CJ, Bennet KE, Garris PA, Blaha CD, Lee KH: Wireless fast-scan cyclic voltammetry to monitor adenosine in patients with essential tremor during deep brain stimulation. Mayo Clin Proc 2012; 87: 760-765.
52. Lakie M, Arblaster LA, Roberts RC, Varma TR: Effect of stereotactic thalamic lesion on essential tremor. Lancet 1992; 340: 206-207.
53. Grill WM, Snyder AN, Miocinovic S: Deep brain stimulation creates an informational lesion of the stimulated nucleus. Neuroreport 2004; 15: 1137-1140.
54. Johnson MD, Miocinovic S, McIntyre CC, Vitek JL: Mechanisms and targets of deep brain stimulation in movement disorders. Neurotherapeutics 2008; 5: 294-308.
55. McIntyre CC, Grill WM, Sherman DL, Thakor NV: Cellular effects of deep brain stimulation: model-based analysis of activation and inhibition. J Neurophysiol 2004; 91: 1457-1469.
56. McIntyre CC, Savasta M, Kerkerian-Le GL, Vitek JL: Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clin Neurophysiol 2004; 115: 1239-1248.
57. Lee KH, Chang SY, Jang DP, Kim I, Goerss S, Van GJ, Min P, Arora K, Marsh M, Hwang SC, Kimble CJ, Garris P, Blaha C, Bennet KE: Emerging techniques for elucidating mechanism of action of deep brain stimulation. Conf Proc IEEE Eng Med Biol Soc 2011; 2011: 677-680.
58. Andrews RJ: Neuromodulation: advances in the next five years. Ann NY Acad Sci 2010; 1199: 204-211.